BIAFW (STOCKS)
bioAffinity Technologies, Inc. Warrant
$0.264400
+0.000000 (+0.00%)
Prev close: $0.264400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Maria Zannes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 57
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $6.78M |
| Benefits Costs and Expenses | $21.48M |
| Costs And Expenses | $21.48M |
| Nonoperating Income/Loss | -$4.32M |
| Operating Expenses | $17.16M |
| Selling, General, and Administrative Expenses | $9.80M |
| Depreciation and Amortization | $534.81K |
| Research and Development | $1.40M |
| Other Operating Expenses | $5.43M |
| Operating Income/Loss | -$10.38M |
| Income/Loss From Continuing Operations After Tax | -$14.74M |
| Income/Loss From Continuing Operations Before Tax | -$14.70M |
| Income Tax Expense/Benefit | $40.86K |
| Net Income/Loss | -$14.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $10.40 |
| Diluted Earnings Per Share | $10.40 |
| Basic Average Shares | 53,095,936 |
| Diluted Average Shares | 53,095,936 |
| Assets | $11.55M |
| Current Assets | $8.61M |
| Inventory | $35.23K |
| Other Current Assets | $8.58M |
| Noncurrent Assets | $2.93M |
| Fixed Assets | $303.12K |
| Intangible Assets | $731.39K |
| Other Non-current Assets | $1.90M |
| Liabilities | $2.64M |
| Current Liabilities | $2.36M |
| Accounts Payable | $940.76K |
| Wages | $717.76K |
| Other Current Liabilities | $701.05K |
| Noncurrent Liabilities | $284.60K |
| Equity | $8.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.90M |
| Liabilities And Equity | $11.55M |
| Net Cash Flow From Operating Activities | -$8.45M |
| Net Cash Flow From Operating Activities, Continuing | -$8.45M |
| Net Cash Flow From Investing Activities | -$60.57K |
| Net Cash Flow From Investing Activities, Continuing | -$60.57K |
| Net Cash Flow From Financing Activities | $15.42M |
| Net Cash Flow From Financing Activities, Continuing | $15.42M |
| Net Cash Flow | $6.91M |
| Net Cash Flow, Continuing | $6.91M |
| Comprehensive Income/Loss | -$14.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.74M |
| Other Comprehensive Income/Loss | $0.00 |